Table 3.
Overview of Treatment-Emergent Adverse Events During UF-EXTEND for Women Who Received Up to 12 Months of Elagolix*
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.